N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?

Research output: Contribution to journalLetterOther

Original languageEnglish
Pages (from-to)2362 - 2363
Number of pages2
JournalTransfusion
Volume54
Issue number9
DOIs
Publication statusPublished - 2014

Cite this

@article{3dabe19b36a34117a8e2542a88d31852,
title = "N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?",
author = "Jake Shortt and Stephen Opat and Wood, {Erica Michelle}",
year = "2014",
doi = "10.1111/trf.12787",
language = "English",
volume = "54",
pages = "2362 -- 2363",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?

AU - Shortt, Jake

AU - Opat, Stephen

AU - Wood, Erica Michelle

PY - 2014

Y1 - 2014

UR - http://onlinelibrary.wiley.com.ezproxy.lib.monash.edu.au/doi/10.1111/trf.12787/abstract

U2 - 10.1111/trf.12787

DO - 10.1111/trf.12787

M3 - Letter

VL - 54

SP - 2362

EP - 2363

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 9

ER -